Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Medical Digital Marketing Agency for Pharma Compliance
India’s Department of Pharmaceuticals rolled out the Uniform Code for Pharmaceutical Marketing Practices (UCPMP 2024) in March 2024. This isn’t a voluntary guideline anymore but a mandatory framework…
|
Tier 2 Pharma Marketing Unlocking India’s Next Growth Wave
Tier 2 pharma marketing drives growth by helping brands engage regional doctors with localized, compliant, and data-driven strategies that boost prescriptions.
|
Doctor Engagement Strategy Shaping the Future of Pharma
Doctor engagement strategy is not just outreach but building meaningful experiences that create trust, deepen loyalty, and deliver stronger long-term results.
|
Engagement Lessons Pharma CMOs Should Steal from Netflix
Why Netflix Should Be in Your Next Marketing Meeting. If you think that's a weird question, we have an answer! If you’re a pharma CMO in India, your biggest challenge isn’t reach. It’s relevance…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
